•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Vingroup has announced a Board resolution to make capital contributions to establish VinSurgical, a new subsidiary focused on medical technology, particularly robotic surgery and advanced medical devices. The move is positioned as part of the group’s continued expansion into high-technology areas with significant research and development content.
VinSurgical will be newly established with charter capital of 300 billion dong. Vingroup will contribute 51%, giving it a controlling stake.
Under the resolution, VinSurgical’s main activities will include research, development and technology transfer in robotic surgery, smart medical devices, and advanced medical support solutions.
Vingroup’s healthcare ecosystem already includes Vinmec, an international private hospital network. In December 2025, Vingroup announced the dissolution of VinMedtech High-Tech Medical Investment Company.
Vinmec has developed since 2012 into a chain of hospitals and clinics in major cities, with several sites earning JCI accreditation, described as one of the world’s most stringent international hospital safety standards.
Vinmec is also noted as the private healthcare unit that first introduced the CORI robotic system for knee replacement surgery.
In recent years, Vingroup has expanded beyond hospital operations into biomedical research and education. Vinmec is linked with VinUni to train doctors, conduct clinical research, and advance medical technology.
Vingroup also integrates AI, big data and biotechnology into healthcare through subsidiaries including VinBrain, VinAI and VinBigData, with the ecosystem expected to continue collaborating with universities, international organizations and large hospitals to raise training and research standards in Vietnam.
Before VinSurgical, Vingroup had three robotics subsidiaries: VinRobotic, VinMotion and VinDynamics. Each has charter capital of 1,000 billion dong, with Vingroup owning 51% in each. VinDynamics has charter capital of 500 billion dong, with Vingroup holding 51%.
In Q1 2026, Vingroup reported consolidated net revenue of 104,352 billion dong, up 24% year on year. Net profit reached 5,611 billion dong, up 150% year on year, driven by growth in industrial manufacturing and real estate.
As of March 31, total assets were nearly 1.2 quadrillion dong. The Q1 results were described as representing about 22% of the revenue plan and 16% of the profit target.
According to Precedence Research, the global robotic surgery market was estimated at USD 12.49 billion in 2025 and is projected to grow from USD 14.45 billion in 2026 to about USD 50.29 billion by 2035, implying a CAGR of 14.95% from 2026 to 2035.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
